The agency has stepped up its campaign against drugmakers' improper listing of patents in the FDA's Orange Book, which it contends are ploys intended to delay generic competition, by disputing junk patent listings for 300 drugs.

The investment firm is among 600 organizations worldwide whose pension funds and benefits plan providers had their participants' data breached recently, and should be "a wake-up call" to all plan sponsors, say industry experts.

Fifty-three percent of Gen Z freelancers perform freelance work for at least 40 hours per week across a portfolio of different types of work.

Employers must act upon this price information to redesign their health plans to better align hospital prices with the value of care provided, since price transparency alone will not lead to changes, according to a new RAND report.

Nearly 4 in 10 adults believe social media has hurt society at large.

The FTC has issued a revised Health Breach Notification Rule, aimed at protecting consumer medical information on digital health and wellness apps, such as GoodRx and Cerebral, by requiring them to notify consumers of a breach.

As Eli Lilly and Novo Nordisk are scrambling to meet demand for their popular weight-loss drugs, Bristol-Myers Squibb is the latest drugmaker to wield the restructuring ax, with plans to cut $1.5 billion in costs by the end of 2025.

Health care companies added 56,000 jobs; warehouse and transportation companies hired 22,000 new workers; and retailers added 20,000.